Pharmaceutical - Antibiotics and Infectious diseases


Popular Filters

176 to 200 of 225 results

Alfa Wassermann and Norgine get EU approval for Xifaxan


Italy-based Alfa Wassermann and Netherlands-headquartered Norgine say they have received European Marketing…

Alfa WassermannAntibiotics and Infectious diseasesEuropeNorginePharmaceuticalRegulationXifaxan

Major constraints in the hospital-treated infections drug market include generic erosion


The hospital-treated infections (HTI) drug market, the loss of patent protection for key branded products…

Antibiotics and Infectious diseasesGenericsGlobalMarkets & MarketingPharmaceuticalResearch

AstraZeneca inks deal for Optimer's fidaxomicin in Latin America


USA-based Optimer Pharmaceuticals (Nasdaq: OPTR) says it has executed an exclusive agreement with Anglo-Swedish…

Antibiotics and Infectious diseasesAstraZenecafidaxomicinLicensingOptimer PharmaceuticalsPharmaceuticalSouth America

Mixed FDA panel vote for Theravance's Vibativ for nosocomial pneumonia


US drug developer Theravance (Nasdaq: THRX) saw its shares rise more than 5% $22.48 by close of trading…

Antibiotics and Infectious diseasesPharmaceuticalRegulationTheravanceVibativ

FDA staffers seem to back safety of Janssen bedaquiline (Sirturo)


Ahead of the November 28 meeting of the US Food and Drug Administration's Anti-Infective Drugs Advisory…

Antibiotics and Infectious diseasesbedaquilineJanssenJohnson & JohnsonNorth AmericaPharmaceuticalRegulationRespiratory and PulmonarySirturo

MicuRx joins forces with VC for next-generation antibiotic for China


MicuRx Pharmaceuticals, a privately-held US biopharmaceutical company developing next-generation antibiotics,…

Antibiotics and Infectious diseasesAsia-PacificMergers & AcquisitionsMicuRx PharmaceuticalsMRX-IPharmaceuticalResearchShanghai MengKe Pharma

Further initiatives from GlaxoSmithKline to help tackle global health challenges; TB deal with Aeras


UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday announced new measures to further advance its commitment…

Antibiotics and Infectious diseasesGlaxoSmithKlineGlobalHealthcarePharmaceuticalResearchVaccines

UCLSA researchers identify new antibiotic that cures disease by disarming pathogens, not killing them


A new type of antibiotic can effectively treat an antibiotic-resistant infection by disarming instead…

Antibiotics and Infectious diseasesPharmaceuticalResearch

New FDA task force will support innovation in antibacterial drug development in USA


The US Food and Drug Administration has announced the formation of an internal task force that will support…

Antibiotics and Infectious diseasesNorth AmericaPharmaceuticalResearch

Red tape delaying access to new TB drug in South Africa


South Africa's drug regulatory authority is placing unreasonable hurdles in the way of desperately ill…

Antibiotics and Infectious diseasesbedaquilineJohnson & JohnsonPharmaceuticalRegulationRest of the World

Pharmaceutical majors unite in Japan to combat H. pylori


On August 31, nine pharmaceutical companies operating in Japan (Kyowa Hakko Kirin, Takeda Pharmaceutical,…

Antibiotics and Infectious diseasesAsia-PacificAstraZenecaGastro-intestinalsPharmaceuticalRegulationTakeda Pharmaceuticals

Janssen-Cilag files for EU approval of bedaquiline in MDR-TB


Johnson & Johnson (NYSE: JNJ) Belgium-based subsidiary Janssen-Cilag International submitted a Marketing…

Antibiotics and Infectious diseasesbedaquilinedelamanidEuropeJanssen-CilagJohnson & JohnsonOtsukaPharmaceuticalRegulation

AstraZeneca poaches Roche exec as CEO; Gets EU approval for Zinforo


Anglo-Swedish drug major AstraZeneca (LSE: AZN) this morning revealed that Pascal Soriot from rival Switzerland-based…

Antibiotics and Infectious diseasesAstraZenecaEuropeManagementPharmaceuticalRegulationRocheZinforo

Common antifungal drug thiabendazole shows promise as cancer therapy


An inexpensive US Food and Drug Administration approved antifungal drug, thiabendazole, slows tumor growth…

Antibiotics and Infectious diseasesOncologyPharmaceuticalResearchthiabendazole

AstraZeneca/BTG abandon CytoFab for sepsis as it fails in Ph IIb


Anglo-Swedish drug major AstraZeneca (LSE: AZN) has decided to halt any further development of AZD9773…

Antibiotics and Infectious diseasesAstraZenecaBTGCytoFabLicensingPharmaceuticalResearch

BioAlliance Pharma out-licenses Oravig to Vestiq Pharma for the USA


BioAlliance Pharma out-licenses Oravig to Vestiq Pharma for the USA

Antibiotics and Infectious diseasesBioAlliance PharmaLicensingLoramycNorth AmericaOravigPharmaceuticalVestiq Pharmaceuticals

UK's NICE launches new medicines advisory service


The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) last Friday launched…

Antibiotics and Infectious diseasesAstellas PharmaBiotechnologyDificlirEuropeGenericsPharmaceuticalRegulation

Single silk device can store and deliver vaccine or antibiotic without costly cold chain


Researchers at the USA-based Tufts University School of Engineering have discovered a way to maintain…

Antibiotics and Infectious diseasesPharmaceuticalResearchVaccines

Boehringer Ingelheim links with Harvard for unmet medical needs research


Family-controlled German drug major Boehringer Ingelheim has established a translational research collaboration…

Antibiotics and Infectious diseasesBoehringer IngelheimOncologyPharmaceuticalResearch

176 to 200 of 225 results



Back to top